Crucial Role of microRNAs as New Targets for Amelogenesis Disorders Detection

被引:0
作者
Masunova, Nadezhda [1 ]
Tereschenko, Maria [1 ]
Alexandrov, Georgy [1 ]
Spirina, Liudmila [1 ,2 ]
Tarasenko, Natalia [1 ,3 ]
机构
[1] Siberian State Med Univ, Minist Hlth Russia, Tomsk 634050, Russia
[2] Russian Acad Sci, Canc Res Inst, Tomsk Natl Res Med Ctr, Tomsk, Russia
[3] Russian Acad Sci, Res Inst Med Genet, Tomsk Natl Res Med Ctr, Tomsk, Russia
关键词
Amelogenesis imperfecta; genetic factors; growth factors; calcium metabolism; microRNA; liquid biopsy; GENE-PRODUCTS; GROWTH-FACTOR; IMPERFECTA; MINERALIZATION; AMELOBLASTIN; EXPRESSION; CHANNELS;
D O I
10.2174/0113894501257011231030161427
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Amelogenesis imperfecta (AI) refers to a heterogeneous group of conditions with multiple factors which contribute to the hypomineralisation of enamel. Preventive measures are necessary to predict this pathology. Prospects for preventive medicine are closely related to the search for new informative methods for diagnosing a human disease. MicroRNAs are prominent for the non-invasive diagnostic platform.The Aim of the Study The aim of the review is to review the heterogeneous factors involved in amelogenesis and to select the microRNA panel associated with the AI type.Methods We used DIANA Tools (algorithms, databases and software) for interpreting and archiving data in a systematic framework ranging from the analysis of expression regulation from deep sequencing data to the annotation of miRNA regulatory elements and targets (https://dianalab.e-ce.uth.gr/). In our study, based on a gene panel associated with the AI types, twenty-four miRNAs were identified for the hypoplastic type (supplement), thirty-five for hypocalcified and forty-nine for hypomaturation AI. The selection strategy included the microRNA search with multiple targets using the AI type's gene panel.Results Key proteins, calcium-dependent and genetic factors were analysed to reveal their role in amelogenesis. The role of extracellular non-coding RNA sequences with multiple regulatory functions seems to be the most attractive. We chose the list of microRNAs associated with the AI genes. We found four microRNAs (hsa-miR-27a-3p, hsa-miR-375, hsa-miR-16-5p and hsa-miR-146a-5p) for the gene panel, associated with the hypoplastic type of AI; five microRNAs (hsa-miR-29c-3p, hsa-miR-124-3p, hsa-miR-1343-3p, hsa-miR-335-5p, and hsa-miR-16-5p - for hypocalcified type of AI, and seven ones (hsa-miR-124-3p, hsa-miR-147a, hsa-miR-16-5p, hsa-miR-429, hsa-let-7b-5p, hsa-miR-146a-5p, hsa-miR-335-5p) - for hypomaturation. It was revealed that hsa-miR-16-5p is included in three panels specific for both hypoplastic, hypocalcified, and hypomaturation types. Hsa-miR-146a-5p is associated with hypoplastic and hypomaturation type of AI, which is associated with the peculiarities of the inflammatory response immune response. In turn, hsa-miR-335-5p associated with hypocalcified and hypomaturation type of AI.Conclusion Liquid biopsy approaches are a promising way to reduce the economic cost of treatment for these patients in modern healthcare. Unique data exist about the role of microRNA in regulating amelogenesis. The list of microRNAs that are associated with AI genes and classified by AI types has been uncovered. The target gene analysis showed the variety of functions of selected microRNAs, which explains the multiple heterogeneous mechanisms in amelogenesis. Predisposition to mineralisation problems is a programmed event. Many factors determine the manifestation of this problem. Additionally, it is necessary to remember the variable nature of the changes, which reduces the prediction accuracy. Therefore, models based on liquid biopsy and microRNAs make it possible to take into account these factors and their influence on the mineralisation. The found data needs further investigation.Conclusion Liquid biopsy approaches are a promising way to reduce the economic cost of treatment for these patients in modern healthcare. Unique data exist about the role of microRNA in regulating amelogenesis. The list of microRNAs that are associated with AI genes and classified by AI types has been uncovered. The target gene analysis showed the variety of functions of selected microRNAs, which explains the multiple heterogeneous mechanisms in amelogenesis. Predisposition to mineralisation problems is a programmed event. Many factors determine the manifestation of this problem. Additionally, it is necessary to remember the variable nature of the changes, which reduces the prediction accuracy. Therefore, models based on liquid biopsy and microRNAs make it possible to take into account these factors and their influence on the mineralisation. The found data needs further investigation.
引用
收藏
页码:1139 / 1149
页数:11
相关论文
共 50 条
  • [1] A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer
    Zhou, Joseph Yi
    Xu, Biao
    Li, Lixin
    DRUG DEVELOPMENT RESEARCH, 2015, 76 (06) : 263 - 269
  • [2] The Role of MicroRNAs and Their Targets in Osteoarthritis
    Gregory R. Sondag
    Tariq M. Haqqi
    Current Rheumatology Reports, 2016, 18
  • [3] The Role of MicroRNAs and Their Targets in Osteoarthritis
    Sondag, Gregory R.
    Haqqi, Tariq M.
    CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (08)
  • [4] MicroRNAs as new therapeutic targets and tools in cancer
    Gandellini, Paolo
    Profumo, Valentina
    Folini, Marco
    Zaffaroni, Nadia
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) : 265 - 279
  • [5] MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
    Momtazi, Amir Abbas
    Banach, Maciej
    Pirro, Matteo
    Stein, Evan A.
    Sahebkar, Amirhossein
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (02) : 224 - 233
  • [6] The new role of microRNAs in cancer
    Perrotti, Danilo
    Eiring, Anna M.
    FUTURE ONCOLOGY, 2010, 6 (08) : 1203 - 1206
  • [7] The crucial role of the TRPM7 kinase domain in the early stage of amelogenesis
    Ogata, Kayoko
    Tsumuraya, Tomoyuki
    Oka, Kyoko
    Shin, Masashi
    Okamoto, Fujio
    Kajiya, Hiroshi
    Katagiri, Chiaki
    Ozaki, Masao
    Matsushita, Masayuki
    Okabe, Koji
    SCIENTIFIC REPORTS, 2017, 7
  • [8] microRNAs as New Targets of Dietary Polyphenols
    Blade, Cinta
    Baselga-Escudero, Laura
    Arola-Arnal, Anna
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (04) : 343 - 351
  • [9] Bone Metastasis-Related MicroRNAs: New Targets for Treatment?
    Zhao, Qian
    Luo, Fengming
    Ma, Junrong
    Yu, Xijie
    CURRENT CANCER DRUG TARGETS, 2015, 15 (08) : 716 - 725
  • [10] Emerging role of microRNAs as novel targets of antidepressants
    Manoharan, Aarthi
    Paul, Abialbon
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 66